Search Results
35 results found-
When integrated with workflows within the laboratory environment to increase laboratory facilities, this advanced technology uses an accuracy, enhance result reproducibility and improve augmented reality headset and a linked tablet, to offer efficiency by decoupling productivity from scientists.
https://www.csl.com/-/media/shared/documents/annual-report/csl-annual-report-2023.pdf -
This function supports our 2030 strategy by and sodium citrate manufacturing facility in the US.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2020-full.pdf -
Biotech leader CSL has manufacturing centers, sales offices, and locations to serve patients and public health around the globe.
https://www.csl.com/we-are-csl/worldwide-locations -
PACE, CSL Behring's end- laboratories and logistics centres in the US, Germany and to-end process transformation, is delivering improved China along with a saline and sodium citrate manufacturing processes which are already demonstrating more efficient facility in the US.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2019-full.pdf -
Eligible patients were at least 18 years old in stable chronic heart failure with New York Heart Association functional class II to IV symptoms, ejection fraction ≤40%, iron deficiency (ferritin <100 ng/mL or ferritin 100-300 ng/mL with a transferrin saturation <20%), and documented heart failure hospitalization or elevated N-terminal pro-brain natriuretic peptide.
https://newsroom.csl.com/2023-08-28-Ferinject-R-granted-upgraded-recommendations-in-2023-ESC-heart-failure-guidelines -
For our executive KMP in 2019, the Board has approved an average 4% increase in Fixed Reward, no increase in STI and an average 30% increase 0% 20% 40% 60% 80% 100% in LTI targets to recognise that our executive KMP LTI component is significantly below global market comparators.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2018-full.pdf -
32 CSL Limited Annual Report 2017 MARIE MCDONALD CHRISTINE O'REILLY MAURICE RENSHAW TADATAKA ‘TACHI' YAMADA KBE ED BAILEY BSc (Hons), LLB (Hons) BBus BPharm MD, BA LLB, BCom, FGIA Age 61 Age 56 Age 70 Age 72 Age 51 Law Finance and Infrastructure International Pharmaceutical Industry International Pharmaceutical Industry (resident in Victoria, Australia) (resident in Victoria, Australia) (resident in New South Wales, Australia) and Medicine Company Secretary Independent:
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2017-full.pdf -
ST. GALLEN, SWITZERLAND, March 28, 2024 / PRNewswire / -- CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least three months.
https://newsroom.csl.com/2024-03-28-Vafseo-R-approved-by-the-U-S-FDA-for-the-treatment-of-anemia-due-to-chronic-kidney-disease-in-dialysis-dependent-adult-patients -
Ready for a challenge? CSL's Summer Internship Program offers roles in Engineering, Manufacturing, Research & Development, Business Operations, and more
https://www.csl.com/careers/early-careers-at-csl/internships/internships-in-the-us -
If you have a rare or chronic condition, start with your doctor and patient advocacy organizations.
https://www.csl.com/we-are-csl/vita-original-stories/2024/looking-for-reliable-health-info